MedTrace Logo

Laser 360iQ: Optimal Light-laser Combination Therapy

NCT04519723 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2020-08-20

No results posted yet for this study

Summary

To assess the safety and efficacy of light-laser combination therapy for the improvement of skin color, tone, texture and laxity

Conditions

  • Photodamage

Interventions

DEVICE

Assess the safety and efficacy of light-laser therapy using the Harmony XL and Dye-VL (500-600nm), Q-Switched 1064nm, Er:YAG 2940nm modules in combination .

Sponsors & Collaborators

  • Alma Lasers Inc.

    lead INDUSTRY

Principal Investigators

  • Brian Zelickson, MD · Board Certified Dermatologist

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04519723 on ClinicalTrials.gov